Food and Drug Administration (FDA) announced that theyve cleared the first generic GLP-1 injectable to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct to diet and exercise. This language likely means that the drug will be available only to diabetics, in contrast to some of the name-brand medications in this class which have been approved for some weight loss cases
Optimized Nutrient Absorption: IV therapy ensures direct delivery of vitamins, minerals, and amino acids into the bloodstream, bypassing digestive issues that may hinder absorption
Dermal Healing Acceleration Pre-Clinical Models & Phase 2 Trials (PubMed, 2012) A review of Thymosin Beta-4s pre-clinical and clinical dermal healing evidence published on PubMed confirmed that TB4 accelerated dermal healing of full-thickness punch wounds across a wide range of animal models including normal rats and mice, steroid-treated rats, diabetic mice, and aged mice
Intravenous infusion of GLP-1 with direct recording of renal sympathetic nerve activity (RSNA) Rats were anesthetized with urethane (0.75 g/kg, i.p.) and -chloralose (70 mg/kg, i.p.)